Sunday, May 14, 2023 1:31:27 PM
Business Updates — 2023
from ECPN Board Chairman Doug Sanders
May 11, 2023
I’m always happy to report good news… and the steps we continue to take to shore up the foundations of our company…
Two updates for today:
We have moved forward with a transition to a new Stock Transfer company… a company that will deliver cutting-edge technology to meet our future needs for communications to Shareholders related to Meeting Notices, Meetings and Elections, and hopefully the disbursement of Dividends. After a good bit of research, we chose a well-regarded national company. The transition process has already begun and we expect it’ll be completed within the next 30 days.
On a related note: I encourage all shareholders to visit the El Capitan Website and register your email and physical mailing address so that our database of shareholders is as robust and accurate as possible. Look for the blue box, bottom left, on the site. Here’s the link: https://www.elcapitanpmi.com/
In our on-going efforts to “clean house” — literally, in this case — I want to report that we have (as reported in 2022) satisfied the delinquent mortgage on the previously privately-owned house and two acres of land located on an ECPN patented Claim. The ownership of that property has now been transferred to our primary operating company, ECPN… which is where we will hold all assets of the company.
It’s very likely I’ll have more to report before the end of the month — and it’s our hope to shift to Weekly Updates as soon as we begin to share news on our joint venture funding (which is progressing nicely) that will open the flood gates of tasks to complete — items that we already have on our “To Do” list — and pave our path to profitability.
Until then, I’ll repeat this mantra:
Keep the faith, think GOLD, and stay tuned for more El Capitan news.
Your El Capitan,
Doug
Sidebar: Whenever I refer to our company as ECPN — our stock symbol — I am referring to the legal entity, El Capitan Precious Metals, Inc.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM